Dec 19, 2011 | Drugs.com
Pulmatrix Presents Data on iSPERSE for Inhaled Combination Drug...
LEXINGTON, Mass.-- --Dec 19, 2011 - Pulmatrix , a clinical stage biotechnology company discovering and developing a new class of therapies for the prevention, treatment and control of respiratory diseases, today announced that its iSPERSE inhaled drug platform demonstrated multi-drug delivery capability and superiority over conventional lactose ... (more)
Martha Rosenberg: Are You Taking These Asthma Drugs?
Big Pharma has been accused of selling drugs that are so dangerous they cause death and drugs that cause the exact conditions they're supposed to treat.
Also on Topix